default author photo

Monika Krzyzanowska

University of Toronto - Princess Margaret Cancer Centre

5th Floor Rm 5-206

610 University Ave

Toronto, ON M5G 2M9 M5G 2M9

Canada

SCHOLARLY PAPERS

1

DOWNLOADS

97

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

A Phase II Study of Durvalumab and Tremelimumab in Patients with Advanced Rare Cancer

Number of pages: 41 Posted: 12 Jun 2024
The Hospital for Sick Children, BC Cancer, University of Ottawa - Ottawa Hospital Research Institute, University of Montreal - Notre-Dame Hospital, Juravinski Hospital - Cancer Centre, Western University, Canada, Cross Cancer Institute, University of British Columbia (UBC), CancerCare Manitoba, University of British Columbia (UBC), University of British Columbia (UBC), University of Toronto - University Health Network, University of Toronto - Princess Margaret Cancer Centre, University of Montreal - Notre-Dame Hospital, University of Ottawa - Ottawa Hospital Research Institute, University of Toronto - Princess Margaret Cancer Centre, University of Toronto - University Health Network, Juravinski Hospital - Cancer Centre, Canadian Cancer Trials Group, Canadian Cancer Trials Group, Canadian Cancer Trials Group and Canadian Cancer Trials Group
Downloads 97 (704,534)

Abstract:

Loading...

checkpoint inhibitors, rare cancers, ovarian carcinoma